The role of circadian rhythm in cardiovascular function - Efficacy of a chronotherapeutic approach to controlling hypertension with Verelan® PM (verapamil HCl)

Today's Therapeutic Trends

Volumn 21, Issue 2, 2003, Pages 201-213

  Prisant, L Michael ^a   Weber, Michael ^b   Black, Henry R ^c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b SUNY Downstate Medical Center   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VERAPAMIL;

ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CHRONOPHARMACOLOGY; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED DRUG RELEASE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; REVIEW;

EID: 0041942600     PISSN: 07412320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Willich SN, Levy D, Rocco MB, et al.: Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am. J. Cardiol. 60:801-806, 1987.
2. Cohen MC, Rohtla KM, Lavery CE, et al.: Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am. J. Cardiol. 79:1512-1515, 1997.
3. Elliott WJ: Circadian variation in the timing of stroke onset. Stroke 29:992-996, 1998.
4. Kario K, Pickering TG, Umeda Y, et al.: Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives - A prospective study. Circulation 107:1401-1406, 2003.
5. Muller JE, Stone PH, Turi ZG, et al.: Circadian variation in the frequency of onset of acute myocardial infarction. N. Engl. J. Med. 313:1315, 1985.
6. Myocardial infarction community registers: Results of a WHO international collaborative study coordinated by the regional office for Europe. In: Public Health in Europe, No. 5. Regional Office for Europe (World Health Organization), Copenhagen, 1976, pp. 1-230.
7. Mitler MM and Kripke DF: Circadian variation in myocardial infarction. N. Engl. J. Med. 314:1187, 1986.
8. Muller J, Ludmer PL, Willich SN, et al.: Circadian variation in the frequency of sudden cardiac death. Circulation 75:131, 1987.
9. Smolensky MH and Portaluppi F: Chronopharmacology and chronotherapy of cardiovascular medications: Relevance to prevention and treatment of coronary heart disease. Am. Heart J. 137(Suppl.):S14-S24, 1999.
10. Millar-Craig MW, Bishop CN and Raftery EB: Circadian variation of blood pressure. Lancet i:795-797, 1978.
11. Tofler GH, Brezinski D, Schafer AI, et al.: Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N. Engl. J. Med. 316:1514-1518, 1987.
12. Prisant LM: Hypertension and chronotherapy: Shifting the treatment paradigm. Am. J. Hypertens. 14:277S-279S, 2001.
13. Prisant LM: Verapamil revisited. A transition in novel drug delivery systems and outcomes. Heart Dis. 3(1):55-60, 2001.
14. Verelan® PM (verapamil HCl) prescribing information. In: Physicians' Desk Reference, 57th Ed. Thompson PDR, Montvale, NJ, 2003, p. 3098.
15. Data on file, Schwarz Pharma, Inc.
16. Smith DHG, Neutel JM and Weber MA: A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning. Am. J. Hypertens. 14:14-19, 2001.
17. Prisant LM, Black HR, Messerli F and Weber M: CHRONO: A community-based hypertension trial of a chronotherapeutic formulation of verapamil. Am. J. Ther. 9(6):476-483, 2002.
18. Krecic-Shepard ME, Barnas CR, Slimko J, et al.: Gender-specific effects on verapamil pharmacokinetics and pharmacodynamics in humans. J. Clin. Pharmacol. 40(3):219-230, 2000.
19. Gupta SK, Atkinson L, Tu T and Longstreth JA: Age and gender related changes in stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil. Br. J. Clin. Pharmacol. 40(4):325-331, 1995.
20. Kaplan NM: Hypertension in the population at large. In: Clinical Hypertension, 6th Ed. Williams & Wilkins, Philadelphia, 1994, pp. 1-22.
21. Burt VL, Whelton P, Roccella EJ, et al.: Prevalence of hypertension in the U.S. adult population: Results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25:305-313, 1995.